Table 2. Cathepsin activities in human... | American Society of Hematology

Table 2.

Cathepsin activities in human plasma

	Cathepsin B	Cathepsin K	Cathepsin S
Gaucher's disease (n = 11)	2.12 ± 0.63^*	5.11 ± 1.39^*	5.63 ± 1.75^*
Nonglycolipid storage diseases (n = 8)	0.95 ± 0.12 (NS)	2.16 ± 0.47 (NS)	2.35 ± 0.90^†
Glycosphingolipidoses (n = 9)	1.97 ± 0.32 (NS)	2.93 ± 1.67 (NS)	4.25 ± 2.99^†
Control subjects (n = 21)	1.17 ± 0.41	1.81 ± 0.46	1.32 ± 0.39

	Cathepsin B	Cathepsin K	Cathepsin S
Gaucher's disease (n = 11)	2.12 ± 0.63^*	5.11 ± 1.39^*	5.63 ± 1.75^*
Nonglycolipid storage diseases (n = 8)	0.95 ± 0.12 (NS)	2.16 ± 0.47 (NS)	2.35 ± 0.90^†
Glycosphingolipidoses (n = 9)	1.97 ± 0.32 (NS)	2.93 ± 1.67 (NS)	4.25 ± 2.99^†
Control subjects (n = 21)	1.17 ± 0.41	1.81 ± 0.46	1.32 ± 0.39

Measurements are given as nmol/min/mL (mean plus or minus SD). NS indicates not significant (P ≥ .05).

Indicates P < .001.

Indicates P < .01.